Omega-6 fatty acids and inflammation.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing human trials, epidemiological studies, and biochemical mechanisms without systematic review methodology.
PubMed 29610056 · doi:10.1016/j.plefa.2018.03.004
What was done
This paper reviewed the mechanistic, clinical, and epidemiological evidence evaluating how dietary omega-6 polyunsaturated fatty acids (arachidonic acid [ARA] and linoleic acid [LA]) affect inflammatory markers and pathways in humans.
What was found
The abstract reports no numerical values or statistical findings. It observes that although ARA serves as a precursor to pro-inflammatory mediators (prostaglandins and leukotrienes), human feeding studies in healthy adults show increased ARA or LA intake does not raise many inflammatory markers. It also notes epidemiological associations with reduced inflammation, alongside evidence that high omega-6 intake may inhibit omega-3 anti-inflammatory actions.
Why it matters
It highlights the divergence between simple biochemical pathway assumptions and actual human physiological responses regarding dietary omega-6 fatty acids and systemic inflammation.
Limits
The abstract describes a non-systematic narrative review providing no quantitative meta-analysis, risk-of-bias assessment, participant counts, specific dosages, or detailed outcome measures.
Cited by
- supports Omega-6 fatty acids can be biochemically converted in the body into arachidonic acid, which can subsequently be metabolized into inflammatory prostaglandins.